UniProt ID | PARP9_HUMAN | |
---|---|---|
UniProt AC | Q8IXQ6 | |
Protein Name | Poly [ADP-ribose] polymerase 9 | |
Gene Name | PARP9 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 854 | |
Subcellular Localization | Cytoplasm, cytosol . Nucleus . Shuttles between the nucleus and the cytosol (PubMed:16809771). Translocates to the nucleus in response to IFNG or IFNB1 stimulation (PubMed:26479788). Export to the cytosol depends on the interaction with DTX3L (PubMed | |
Protein Description | ADP-ribosyltransferase which, in association with E3 ligase DTX3L, plays a role in DNA damage repair and in immune responses including interferon-mediated antiviral defenses. [PubMed: 16809771] | |
Protein Sequence | MDFSMVAGAAAYNEKSGRITSLSLLFQKVFAQIFPQWRKGNTEECLPYKCSETGALGENYSWQIPINHNDFKILKNNERQLCEVLQNKFGCISTLVSPVQEGNSKSLQVFRKMLTPRIELSVWKDDLTTHAVDAVVNAANEDLLHGGGLALALVKAGGFEIQEESKQFVARYGKVSAGEIAVTGAGRLPCKQIIHAVGPRWMEWDKQGCTGKLQRAIVSILNYVIYKNTHIKTVAIPALSSGIFQFPLNLCTKTIVETIRVSLQGKPMMSNLKEIHLVSNEDPTVAAFKAASEFILGKSELGQETTPSFNAMVVNNLTLQIVQGHIEWQTADVIVNSVNPHDITVGPVAKSILQQAGVEMKSEFLATKAKQFQRSQLVLVTKGFNLFCKYIYHVLWHSEFPKPQILKHAMKECLEKCIEQNITSISFPALGTGNMEIKKETAAEILFDEVLTFAKDHVKHQLTVKFVIFPTDLEIYKAFSSEMAKRSKMLSLNNYSVPQSTREEKRENGLEARSPAINLMGFNVEEMYEAHAWIQRILSLQNHHIIENNHILYLGRKEHDILSQLQKTSSVSITEIISPGRTELEIEGARADLIEVVMNIEDMLCKVQEEMARKKERGLWRSLGQWTIQQQKTQDEMKENIIFLKCPVPPTQELLDQKKQFEKCGLQVLKVEKIDNEVLMAAFQRKKKMMEEKLHRQPVSHRLFQQVPYQFCNVVCRVGFQRMYSTPCDPKYGAGIYFTKNLKNLAEKAKKISAADKLIYVFEAEVLTGFFCQGHPLNIVPPPLSPGAIDGHDSVVDNVSSPETFVIFSGMQAIPQYLWTCTQEYVQSQDYSSGPMRPFAQHPWRGFASGSPVD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MDFSMVAGAAA ----CCHHHHCCHHH | 14.21 | 25850435 | |
12 | Phosphorylation | MVAGAAAYNEKSGRI HHCCHHHCCCCCCCC | 21.09 | 25850435 | |
18 (in isoform 2) | Phosphorylation | - | 35.78 | 27251275 | |
49 | Ubiquitination | TEECLPYKCSETGAL CCCCCCEECCCCCCC | 29.37 | - | |
51 | Phosphorylation | ECLPYKCSETGALGE CCCCEECCCCCCCCC | 33.76 | 27251275 | |
53 | Phosphorylation | LPYKCSETGALGENY CCEECCCCCCCCCCE | 16.09 | 27251275 | |
61 | Phosphorylation | GALGENYSWQIPINH CCCCCCEEEEEECCC | 24.88 | 24247654 | |
72 | Ubiquitination | PINHNDFKILKNNER ECCCCCCHHHCCCHH | 50.41 | - | |
75 | Ubiquitination | HNDFKILKNNERQLC CCCCHHHCCCHHHHH | 62.29 | - | |
88 | Ubiquitination | LCEVLQNKFGCISTL HHHHHHHHCCHHHCC | 30.12 | - | |
105 | Ubiquitination | PVQEGNSKSLQVFRK CCCCCCCCHHHHHHH | 60.22 | - | |
121 | Phosphorylation | LTPRIELSVWKDDLT HCCCEEEEEECCHHH | 17.09 | 22496350 | |
166 | Ubiquitination | FEIQEESKQFVARYG CCCCHHHHHHHHHHC | 51.54 | - | |
172 | Phosphorylation | SKQFVARYGKVSAGE HHHHHHHHCCCCHHE | 16.15 | 22817900 | |
174 | Ubiquitination | QFVARYGKVSAGEIA HHHHHHCCCCHHEEE | 24.87 | - | |
191 | Ubiquitination | GAGRLPCKQIIHAVG CCCCCCHHHHHHHHC | 42.46 | - | |
206 | Ubiquitination | PRWMEWDKQGCTGKL CCHHCCCCCCCCHHH | 50.06 | - | |
273 | Ubiquitination | KPMMSNLKEIHLVSN CCCCCCCEEEEEECC | 59.89 | - | |
279 | Phosphorylation | LKEIHLVSNEDPTVA CEEEEEECCCCHHHH | 40.64 | 22210691 | |
289 | Ubiquitination | DPTVAAFKAASEFIL CHHHHHHHHHHHHHC | 38.01 | - | |
361 | Ubiquitination | QQAGVEMKSEFLATK HHHCCCHHHHHHHHH | 33.07 | - | |
362 | Phosphorylation | QAGVEMKSEFLATKA HHCCCHHHHHHHHHH | 32.07 | 24719451 | |
368 | Ubiquitination | KSEFLATKAKQFQRS HHHHHHHHHHHHCHH | 48.24 | - | |
368 | Malonylation | KSEFLATKAKQFQRS HHHHHHHHHHHHCHH | 48.24 | 32601280 | |
411 | Ubiquitination | QILKHAMKECLEKCI HHHHHHHHHHHHHHH | 46.16 | - | |
455 | Ubiquitination | DEVLTFAKDHVKHQL HHHHHHHHHHHHCCE | 44.14 | - | |
459 | Ubiquitination | TFAKDHVKHQLTVKF HHHHHHHHCCEEEEE | 23.39 | - | |
477 | Ubiquitination | PTDLEIYKAFSSEMA ECCHHHHHHHCHHHH | 48.92 | - | |
485 | Ubiquitination | AFSSEMAKRSKMLSL HHCHHHHHHHCCCCC | 56.76 | - | |
487 | Phosphorylation | SSEMAKRSKMLSLNN CHHHHHHHCCCCCCC | 23.01 | 28634298 | |
488 | Ubiquitination | SEMAKRSKMLSLNNY HHHHHHHCCCCCCCC | 48.14 | - | |
491 | Phosphorylation | AKRSKMLSLNNYSVP HHHHCCCCCCCCCCC | 26.08 | 21945579 | |
495 | Phosphorylation | KMLSLNNYSVPQSTR CCCCCCCCCCCHHHH | 15.24 | 21945579 | |
496 | Phosphorylation | MLSLNNYSVPQSTRE CCCCCCCCCCHHHHH | 29.46 | 21945579 | |
500 | Phosphorylation | NNYSVPQSTREEKRE CCCCCCHHHHHHHHH | 24.30 | 21945579 | |
501 | Phosphorylation | NYSVPQSTREEKREN CCCCCHHHHHHHHHC | 36.53 | 21945579 | |
563 | Phosphorylation | RKEHDILSQLQKTSS CCHHHHHHHHHHCCC | 29.22 | 28122231 | |
569 | Phosphorylation | LSQLQKTSSVSITEI HHHHHHCCCCEEEEE | 35.46 | 28985074 | |
572 | Phosphorylation | LQKTSSVSITEIISP HHHCCCCEEEEEECC | 26.24 | 28985074 | |
574 | Phosphorylation | KTSSVSITEIISPGR HCCCCEEEEEECCCC | 17.39 | 28985074 | |
597 (in isoform 2) | Ubiquitination | - | 1.25 | 21890473 | |
627 | Phosphorylation | WRSLGQWTIQQQKTQ HHHHHHHHHHCCCCH | 10.87 | 28857561 | |
632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
632 (in isoform 1) | Ubiquitination | - | 43.76 | 21890473 | |
637 | Sulfoxidation | QQKTQDEMKENIIFL CCCCHHHHHHCEEEE | 9.93 | 21406390 | |
638 | Ubiquitination | QKTQDEMKENIIFLK CCCHHHHHHCEEEEE | 45.63 | - | |
645 | Ubiquitination | KENIIFLKCPVPPTQ HHCEEEEECCCCCHH | 26.24 | - | |
651 | Phosphorylation | LKCPVPPTQELLDQK EECCCCCHHHHHHHH | 28.71 | 23532336 | |
659 | Ubiquitination | QELLDQKKQFEKCGL HHHHHHHHHHHHHCC | 55.37 | - | |
663 | Ubiquitination | DQKKQFEKCGLQVLK HHHHHHHHHCCEEEE | 34.59 | - | |
680 | Sulfoxidation | KIDNEVLMAAFQRKK ECCHHHHHHHHHHHH | 2.82 | 21406390 | |
693 | Acetylation | KKKMMEEKLHRQPVS HHHHHHHHHHCCCCH | 35.97 | 7355457 | |
705 (in isoform 2) | Ubiquitination | - | 48.21 | 21890473 | |
740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
740 (in isoform 1) | Ubiquitination | - | 50.84 | 21890473 | |
743 | Ubiquitination | IYFTKNLKNLAEKAK EECCCCHHHHHHHHH | 60.35 | - | |
849 | Phosphorylation | HPWRGFASGSPVD-- CCCCCCCCCCCCC-- | 37.23 | 23090842 | |
851 | Phosphorylation | WRGFASGSPVD---- CCCCCCCCCCC---- | 21.18 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PARP9_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PARP9_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PARP9_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DTX3L_HUMAN | DTX3L | physical | 12670957 | |
PARP1_HUMAN | PARP1 | physical | 24886089 | |
PAR14_HUMAN | PARP14 | physical | 24886089 | |
DTX3L_HUMAN | DTX3L | physical | 24886089 | |
STAT1_HUMAN | STAT1 | physical | 26479788 | |
DTX3L_HUMAN | DTX3L | physical | 26479788 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...